Viridian Therapeutics, Inc.\DE SEC filings VRDN
Viridian Therapeutics, Inc.\DE has 817 filings in SEC EDGAR's recent list, going back to Nov 12, 2013. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 29, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Agreement ended
|
May 28, 2026 | May 27, 2026 |
| 8-K |
Current report
Material agreement
|
May 26, 2026 | May 24, 2026 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
May 11, 2026 | May 6, 2026 |
| 424B5 | Prospectus supplement | May 8, 2026 | — |
| 424B5 | Prospectus supplement | May 8, 2026 | — |
| FWP | Free writing prospectus | May 7, 2026 | — |
| FWP | Free writing prospectus | May 7, 2026 | — |
| 305B2 | Filing | May 7, 2026 | — |
| 424B5 | Prospectus supplement | May 6, 2026 | — |
| 424B5 | Prospectus supplement | May 6, 2026 | — |
| FWP | Free writing prospectus | May 5, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 5, 2026 | May 5, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 17, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 17, 2026 | — |
| DEF 14A | Proxy statement | Apr 17, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 30, 2026 | Mar 30, 2026 |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Material agreement
|
Oct 23, 2025 | Oct 21, 2025 |
| 424B5 | Prospectus supplement | Oct 23, 2025 | — |
| 424B5 | Prospectus supplement | Oct 21, 2025 | — |
| 8-K |
Current report
Results of operations
|
Oct 21, 2025 | Oct 21, 2025 |
| 8-K |
Current report
Material agreement
|
Oct 20, 2025 | Oct 17, 2025 |
| S-3ASR | Automatic shelf registration | Sep 5, 2025 | — |
| S-8 | Employee stock plan registration | Aug 6, 2025 | — |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 30, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 24, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2025 | May 20, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 7, 2025 | Apr 2, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 10, 2025 | Mar 5, 2025 |
| 424B5 | Prospectus supplement | Mar 4, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Mar 4, 2025 | Mar 3, 2025 |
| S-8 | Employee stock plan registration | Mar 3, 2025 | — |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 10, 2025 | Jan 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2024 | Nov 12, 2024 |
| 424B5 | Prospectus supplement | Sep 13, 2024 | — |
| 8-K |
Current report
Material agreement
|
Sep 12, 2024 | Sep 11, 2024 |
| 424B5 | Prospectus supplement | Sep 10, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 10, 2024 | Sep 10, 2024 |
| S-8 | Employee stock plan registration | Aug 12, 2024 | — |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 15, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 20, 2024 | Jun 17, 2024 |
| DEFA14A | Additional proxy material | Jun 10, 2024 | — |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Material agreement
|
Apr 16, 2024 | Apr 10, 2024 |
| S-8 | Employee stock plan registration | Feb 28, 2024 | — |
| 10-K | Annual report | Feb 27, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Jan 19, 2024 | Jan 17, 2024 |
| 424B5 | Prospectus supplement | Jan 19, 2024 | — |
| 424B5 | Prospectus supplement | Jan 17, 2024 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 8, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Dec 18, 2023 | Dec 15, 2023 |
| S-3ASR | Automatic shelf registration | Nov 30, 2023 | — |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Nov 2, 2023 | Oct 29, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Oct 30, 2023 | Oct 29, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 25, 2023 | Sep 21, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 12, 2023 | Sep 8, 2023 |
| S-8 | Employee stock plan registration | Aug 8, 2023 | — |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| S-3ASR | Automatic shelf registration | Jul 24, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 17, 2023 | Jul 17, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 10, 2023 | Jul 10, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 16, 2023 | Jun 14, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 14, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2023 | Apr 11, 2023 |
| S-8 | Employee stock plan registration | Mar 10, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 10-K | Annual report | Mar 9, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2023 | Mar 8, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Feb 6, 2023 | Feb 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 8, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| S-3ASR | Automatic shelf registration | Sep 9, 2022 | — |
| 8-K |
Current report
Material agreement
|
Aug 19, 2022 | Aug 16, 2022 |
| 424B5 | Prospectus supplement | Aug 18, 2022 | — |
| 424B3 | Prospectus | Aug 17, 2022 | — |
| 8-K |
Current report
Other events
|
Aug 16, 2022 | Aug 15, 2022 |
| S-8 POS | Filing | Aug 16, 2022 | — |
| S-8 POS | Filing | Aug 16, 2022 | — |
| S-8 | Employee stock plan registration | Aug 16, 2022 | — |
| 424B5 | Prospectus supplement | Aug 15, 2022 | — |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 23, 2022 | Jun 21, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 8, 2022 |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2022 | May 12, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2022 | — |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Apr 5, 2022 | Apr 1, 2022 |
| S-8 | Employee stock plan registration | Mar 11, 2022 | — |
| 10-K | Annual report | Mar 11, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| EFFECT | Filing | Nov 17, 2021 | — |
| CORRESP | Letter to the SEC | Nov 15, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 10, 2021 | — |
| 8-K |
Current report
Other events
|
Nov 8, 2021 | Nov 8, 2021 |
| S-3 | Shelf registration | Nov 8, 2021 | — |
| 10-Q | Quarterly report | Nov 5, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Sep 23, 2021 | Sep 20, 2021 |
| 424B5 | Prospectus supplement | Sep 22, 2021 | — |
| 424B5 | Prospectus supplement | Sep 20, 2021 | — |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 26, 2021 | Jul 26, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 15, 2021 | Jul 14, 2021 |
| 8-K/A |
Amended current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 15, 2021 | Jun 3, 2021 |
| DEFA14A | Additional proxy material | Jun 4, 2021 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 4, 2021 | Jun 3, 2021 |
| 8-K |
Current report
Officer or director change
|
May 17, 2021 | May 14, 2021 |
| 10-Q | Quarterly report | May 7, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| DEF 14A | Proxy statement | Apr 30, 2021 | Apr 30, 2021 |
| 8-K |
Current report
Material agreement
|
Apr 26, 2021 | Apr 23, 2021 |
| 424B3 | Prospectus | Apr 23, 2021 | — |
| 424B5 | Prospectus supplement | Apr 23, 2021 | — |
| PRE 14A | Preliminary proxy statement | Apr 14, 2021 | Apr 14, 2021 |
| S-8 | Employee stock plan registration | Mar 26, 2021 | — |
| 10-K | Annual report | Mar 26, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2021 | Mar 25, 2021 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Other events
|
Jan 20, 2021 | Jan 15, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
|
Jan 4, 2021 | Dec 31, 2020 |
| 424B5 | Prospectus supplement | Dec 23, 2020 | — |
| EFFECT | Filing | Dec 22, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2020 | — |
| CORRESP | Letter to the SEC | Dec 21, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2020 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 17, 2020 | Dec 16, 2020 |
| S-3 | Shelf registration | Dec 15, 2020 | — |
| DEF 14A | Proxy statement | Dec 14, 2020 | Dec 31, 2020 |
| 424B5 | Prospectus supplement | Dec 11, 2020 | — |
| 8-K |
Current report
Other events
|
Dec 9, 2020 | Dec 9, 2020 |
| CORRESP | Letter to the SEC | Dec 8, 2020 | — |
| PRER14A | Filing | Dec 8, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Dec 4, 2020 | Dec 2, 2020 |
| S-8 | Employee stock plan registration | Nov 24, 2020 | — |
| PRE 14A | Preliminary proxy statement | Nov 20, 2020 | Nov 20, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Nov 13, 2020 | Nov 12, 2020 |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2020 | Nov 10, 2020 |
| D | Filing | Nov 6, 2020 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 28, 2020 | Oct 27, 2020 |
| 8-K |
Current report
Listing notice
|
Oct 14, 2020 | Oct 8, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 5, 2020 | Oct 5, 2020 |
| 8-K/A |
Amended current report
Officer or director change
|
Oct 1, 2020 | Sep 13, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Sep 17, 2020 | Sep 13, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2020 | Aug 20, 2020 |
| 10-Q | Quarterly report | Aug 5, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2020 | Aug 5, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 24, 2020 | Jul 23, 2020 |
| 8-K |
Current report
Other events
|
Jul 2, 2020 | Jul 2, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 23, 2020 | Jun 22, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 19, 2020 | Jun 16, 2020 |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2020 | May 22, 2020 |
| 10-Q | Quarterly report | May 8, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Apr 27, 2020 | Apr 27, 2020 |
| EFFECT | Filing | Apr 14, 2020 | — |
| CORRESP | Letter to the SEC | Apr 10, 2020 | — |
| DEFA14A | Additional proxy material | Apr 10, 2020 | — |
| DEF 14A | Proxy statement | Apr 10, 2020 | Apr 10, 2020 |
| UPLOAD | Letter from the SEC | Apr 1, 2020 | — |
| PRE 14A | Preliminary proxy statement | Mar 27, 2020 | Mar 27, 2020 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VRDN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1590750
- Former names
- MIRAGEN THERAPEUTICS, INC. (until Jan 15, 2021); SIGNAL GENETICS, INC. (until Feb 10, 2017); SIGNAL GENETICS LLC (until Jul 9, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.